The HSPB1 (Ab-15) Antibody has been validated for use in multiple experimental techniques with specific recommended dilutions to ensure optimal performance . Proper dilution is critical for obtaining specific signal with minimal background.
| Technique | Recommended Dilution |
|---|---|
| Immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded sections | 1:50-1:100 |
| Western Blot (WB) | 1:500-1:1000 |
Understanding the target protein is essential for effective utilization of the HSPB1 (Ab-15) Antibody. HSPB1 is a ubiquitously expressed molecular chaperone belonging to the small heat shock protein family . It plays critical roles in cellular stress response and protein quality control mechanisms.
HSPB1 contains an alpha-crystallin domain (ACD) that is characteristic of small heat shock proteins . The protein forms dynamic oligomeric structures that can change in response to cellular conditions and post-translational modifications. Under normal physiological conditions, HSPB1 forms large oligomeric assemblies that can dissociate into smaller oligomers upon stress or phosphorylation .
Research utilizing structural analysis has revealed that disease-causing mutations in HSPB1 can significantly alter its quaternary structure. Particularly, mutations such as R127W, S135F, and R136W induce dramatic changes to the quaternary structure despite minimal effects on thermal stability . At high concentrations or under molecular crowding conditions, these mutant forms create assemblies approximately twice the size of wild-type HSPB1 structures .
HSPB1 serves multiple functions within cells, including:
Protein folding assistance and prevention of protein aggregation
Regulation of cellular stress response
Modulation of inflammatory processes
Participation in autophagy pathways
Recent research has demonstrated that HSPB1 is necessary for autophagosome formation, a critical step in the autophagy process . Wild-type HSPB1 interacts with the autophagy receptor SQSTM1/p62 through the latter's PB1 domain, facilitating the formation of SQSTM1/p62 bodies that are essential for phagophore formation .
Additionally, HSPB1 can be secreted from astrocytes to mediate non-cell-autonomous protective functions in the central nervous system . Extracellular HSPB1 has been shown to dampen inflammatory responses in astrocyte cultures and ex vivo models, suggesting a broader role in neuroprotection .
The HSPB1 (Ab-15) Antibody serves as a valuable tool for investigating HSPB1 expression, localization, and function across various experimental contexts.
In immunohistochemistry, the HSPB1 (Ab-15) Antibody enables visualization of HSPB1 protein expression patterns in formalin-fixed, paraffin-embedded tissue sections . This application is particularly valuable for examining HSPB1 expression in neural tissues affected by neurodegenerative disorders such as Charcot-Marie-Tooth disease.
When used at the recommended dilution of 1:50-1:100, the antibody provides specific staining of HSPB1 in human tissue samples . This specificity allows researchers to examine the distribution and expression levels of HSPB1 in normal versus diseased tissues.
For western blot analysis, the HSPB1 (Ab-15) Antibody enables quantitative assessment of HSPB1 protein levels in tissue or cell lysates . When used at the recommended dilution of 1:500-1:1000, the antibody specifically detects HSPB1 at approximately 27 kDa .
Western blotting applications of this antibody are particularly useful for:
Comparing HSPB1 expression levels between different experimental conditions
Detecting post-translational modifications of HSPB1
Validating knockdown or overexpression of HSPB1 in experimental models
Research utilizing antibodies against HSPB1, including the HSPB1 (Ab-15) Antibody, has significantly advanced our understanding of HSPB1's role in various pathological conditions, particularly neurodegenerative disorders.
Mutations in the HSPB1 gene have been linked to Charcot-Marie-Tooth (CMT) disease, a commonly occurring peripheral neuropathy, and distal hereditary motor neuropathy (dHMN) . CMT disease is characterized by progressive degeneration of the foot, lower leg, hand, and forearm muscles, accompanied by distal sensory loss .
Specific autosomal dominant HSPB1 mutations, including R127W, S135F, and R136W, have been extensively studied . These mutations induce significant alterations to HSPB1's quaternary structure, affecting its oligomerization and interactions with partner proteins such as HSPB6 . At low concentrations, mutant HSPB1 proteins show a higher propensity to dissociate into small oligomers, and this dissociation is enhanced by MAPKAP kinase-2 mediated phosphorylation for the R127W and R135F mutants .
Recent research has revealed that mutations in HSPB1 lead to impairment of macroautophagy/autophagic flux . Studies utilizing HSPB1 knockout cells have demonstrated that HSPB1 is necessary for autophagosome formation, and this function can be rescued upon re-expression of wild-type HSPB1 .
Wild-type HSPB1 protein binds to the autophagy receptor SQSTM1/p62, with the PB1 domain of SQSTM1 being essential for this interaction . Mutations in HSPB1 decrease the formation of SQSTM1/p62 bodies and subsequently impair phagophore formation, suggesting a regulatory role for HSPB1 in autophagy via interaction with SQSTM1 .
Notably, these autophagy deficits have been confirmed in patient-derived motor neurons, indicating that autophagy impairment might be one of the pathomechanisms by which mutations in HSPB1 lead to peripheral neuropathy .
Recent findings indicate that HSPB1 is secreted from astrocytes and exerts non-cell-autonomous protective functions . Extracellular HSPB1 has been shown to dampen inflammatory responses in astrocyte cultures and ex vivo models .
In primary mouse astrocytes, treatment with recombinant human HSPB1 (rhHSPB1) ameliorates reactive inflammatory responses, as evidenced by reduced markers of astrocyte reactivity and decreased secretion of mediators of neurotoxicity and inflammation such as LCN2 . Similar effects have been observed in organotypic brain slices, where the presence of HSPB1 in the extracellular environment diminishes the inflammatory reaction in astrocytes .
Furthermore, increased expression of human HSPB1 in astrocytes or treatment with recombinant HSPB1 can reduce the accumulation of aggregated tau in brain slice models, suggesting a potential role in mitigating tauopathies .
The HSPB1 (Ab-15) Antibody can be incorporated into various experimental protocols to investigate HSPB1's expression, localization, and function.
For quantitative assessment of HSPB1 protein levels, western blot analysis utilizing the HSPB1 (Ab-15) Antibody at a dilution of 1:500-1:1000 is recommended . This approach allows researchers to:
Compare HSPB1 expression levels between different experimental conditions
Assess the impact of gene knockdown or overexpression on HSPB1 protein levels
Evaluate the effects of various treatments on HSPB1 expression
Immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections using the HSPB1 (Ab-15) Antibody at a dilution of 1:50-1:100 enables visualization of HSPB1 distribution in tissues . This approach is particularly valuable for:
Examining HSPB1 expression patterns in normal versus diseased tissues
Investigating cell-type specific expression of HSPB1
Correlating HSPB1 localization with pathological features
To ensure optimal results when working with the HSPB1 (Ab-15) Antibody, researchers should adhere to the following best practices:
While recommended dilutions for various applications are provided (1:50-1:100 for immunohistochemistry and 1:500-1:1000 for western blot) , researchers may need to optimize these dilutions based on their specific experimental conditions, sample types, and detection systems.
For western blot applications, optimization of blocking conditions, incubation times, and washing steps may be necessary to minimize background and maximize specific signal. Similarly, for immunohistochemistry, optimization of antigen retrieval methods, blocking conditions, and detection systems may enhance staining specificity and intensity.
What is HSPB1 and why is its phosphorylation at Serine 15 significant?
HSPB1, also known as HSP27, is a member of the small heat shock protein (HSP20) family with a molecular weight of 22.8 kDa and 205 amino acid residues in humans. It primarily localizes to the nucleus and cytoplasm and is widely expressed across various tissue types. HSPB1 plays critical roles in intracellular signal transduction and the regulation of apoptosis, functioning as a molecular chaperone under stress conditions .
Phosphorylation at Serine 15 (S15) represents one of the key post-translational modifications that regulate HSPB1 function. This specific phosphorylation event is particularly important in cellular responses to mechanical stimulation. Research demonstrates that phosphorylation of HSPB1 is required for normal cell behaviors including actin cytoskeletal remodeling, cell spreading, and cell migration . The ability to specifically detect this phosphorylation state using the Ab-15 antibody enables precise investigation of mechanotransduction pathways.
Mechanistically, HSPB1 phosphorylation alters its oligomerization state and interaction with cellular components, particularly the actin cytoskeleton. When phosphorylated at S15, HSPB1 shifts from larger to smaller oligomers, changing its binding properties and cellular functions .
What experimental applications is the HSPB1 (Ab-15) Antibody validated for?
The HSPB1 (Ab-15) Antibody has been validated for multiple experimental applications in research settings. Based on available data, the following applications have been confirmed:
| Application | Recommended Dilution | Sample Types | Expected Results |
|---|---|---|---|
| Western Blotting | 1:1000 | Cell/tissue lysates | ~23 kDa band |
| Immunohistochemistry (IHC) | 1:250 | FFPE tissue sections | Cellular localization |
| Immunoprecipitation (IP) | As per manufacturer | Cell lysates | Protein complex isolation |
The antibody demonstrates reactivity against human, mouse, and rat phospho-HSPB1, making it versatile for comparative studies across these species . This cross-species reactivity is particularly valuable for translational research comparing model organisms with human samples.
For Western blotting applications, the antibody typically detects a single band at approximately 23 kDa, corresponding to phosphorylated HSPB1. In IHC applications, it enables visualization of phospho-HSPB1 distribution within tissues and cellular compartments, with particularly strong signals observed in tissues under stress conditions or mechanical stimulation .
How should samples be prepared to preserve HSPB1 phosphorylation status?
Preserving the phosphorylation status of HSPB1 is critical for accurate experimental results with the Ab-15 antibody. Phosphorylation states can be highly labile, and improper sample handling may lead to artifactual dephosphorylation. Consider the following methodological approach:
Pre-chill all buffers and equipment to 4°C
Include phosphatase inhibitors in lysis buffer: sodium fluoride (50 mM), sodium orthovanadate (1 mM), β-glycerophosphate (10 mM), and phosphatase inhibitor cocktail
Use a buffer composition of PBS with 0.02% sodium azide, 50% glycerol, pH 7.3, supplemented with protease inhibitors
Process samples quickly at 4°C
For adherent cells, consider direct lysis on plate after quick washing with ice-cold PBS containing phosphatase inhibitors
Snap-freeze tissues/cells in liquid nitrogen immediately after collection
Store samples at -80°C
Avoid repeated freeze-thaw cycles
For long-term storage, consider adding 50% glycerol to stabilize proteins
These methodological precautions help maintain the phosphorylation state of HSPB1, ensuring accurate detection of the S15 phosphorylated form and reducing false-negative results. The addition of phosphatase inhibitors is particularly crucial as phosphorylation can be rapidly lost during sample preparation.
What validation strategies confirm the specificity of HSPB1 (Ab-15) Antibody?
Validating antibody specificity is crucial for generating reliable research data. For phospho-specific antibodies like HSPB1 (Ab-15), implement these methodological approaches:
Split your sample into two equal portions
Treat one portion with lambda phosphatase (400 U/mL) for 30 minutes at 30°C
Run both treated and untreated samples on the same gel
Probe with the phospho-specific antibody
Expect signal loss or significant reduction in the phosphatase-treated sample
Use CRISPR-Cas9 engineered HSPB1-null cells as a negative control
Compare antibody reactivity in cells expressing:
Wild-type HSPB1
S15A (phospho-dead) mutant
S15E (phospho-mimetic) mutant
Prepare working dilution of antibody
Split into two portions
Pre-incubate one portion with excess phospho-S15 peptide (100-200 μg/mL)
Pre-incubate second portion with non-phosphorylated peptide at same concentration
Use both antibody preparations on identical samples
Expect signal blocking only with the phospho-peptide
Research has demonstrated that CRISPR-Cas9 engineered HSPB1-null cells provide an excellent negative control for antibody validation . These cells show no reactivity with the antibody, confirming specificity. When these cells are reconstituted with various HSPB1 constructs, only those containing phosphorylatable serine residues show positive signals with phospho-specific antibodies.
What experimental models are optimal for studying HSPB1 phosphorylation dynamics?
Several experimental models have proven effective for investigating HSPB1 phosphorylation dynamics in research settings:
CRISPR-Cas9 Engineered Cell Models:
CRISPR-Cas9 engineered HSPB1-null cells provide a clean genetic background for rescue experiments . This model allows researchers to compare wild-type versus phosphomutant HSPB1 function by reintroducing different HSPB1 variants. Research has shown that only phosphorylatable HSPB1, not phospho-dead mutants, can rescue certain cellular phenotypes in these knockout models .
Substrate stretching systems: Apply controlled cyclic or static stretch to adherent cells and analyze phospho-HSPB1 levels at different time points
Micropatterned substrates: Force cells to adopt specific geometries (e.g., 47 μm × 47 μm squares) that create predictable tension patterns
Atomic force microscopy (AFM): Apply localized mechanical force and observe real-time phosphorylation responses
Research has established that cells cultured on micropatterned substrates reliably exhibit localization of mechanosensitive proteins like zyxin and HSPB1 to high-tension areas such as cell corners, edges, and actin comet tails, making this an excellent model for studying phospho-HSPB1 dynamics . These geometrically constrained cells create reproducible patterns of mechanical stress that can be systematically analyzed.
The knockout-rescue approach is particularly powerful, as it allows direct comparison of wild-type and mutant HSPB1 functions in an identical cellular background. Studies have demonstrated that wild-type HSPB1, but not non-phosphorylatable HSPB1 mutants, rescues certain characteristics in HSPB1-null cells, including enhanced cell motility and deficient actin reinforcement following stretch stimulation .
How can phospho-HSPB1 localization be visualized in relation to cytoskeletal structures?
Visualizing phospho-HSPB1 in relation to cytoskeletal structures requires specialized imaging techniques and careful experimental design:
Culture cells on appropriate substrates (glass coverslips or micropatterned surfaces)
Fix cells with 4% paraformaldehyde (10 minutes, room temperature)
Permeabilize with 0.1% Triton X-100 (5 minutes)
Block with 3% BSA in PBS (1 hour)
Incubate with HSPB1 (Ab-15) antibody at optimized dilution (overnight, 4°C)
Add fluorophore-conjugated secondary antibody (1 hour, room temperature)
Co-stain for:
Mount and image using confocal microscopy
Research findings have demonstrated that phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers and is recruited to high-tension structures in geometrically constrained cells, such as actin comet tails emanating from focal adhesions . These observations were made possible through careful co-localization studies with cytoskeletal markers.
For advanced analysis, super-resolution microscopy techniques such as STORM, PALM, or SIM can resolve nanoscale co-localization between phospho-HSPB1 and cytoskeletal elements. Research has used confocal microscopy to localize HSPB1 along with the focal adhesion protein vinculin and F-actin in subcellular contexts, revealing that HSPB1 could be found in linear elements associated with the cytoskeleton .
How does mechanical stress regulate HSPB1 phosphorylation, and what experimental setups can capture this phenomenon?
Mechanical stress is a key regulator of HSPB1 phosphorylation, activating specific signaling pathways that modify HSPB1 function. Understanding this regulation requires specialized experimental approaches:
Substrate stretching: Using flexible membranes (e.g., silicone) coated with ECM proteins
Micropatterned substrates:
Research has demonstrated that wild-type HSPB1, but not non-phosphorylatable HSPB1 mutants, rescues certain characteristics in HSPB1-null cells following mechanical stimulation, including enhanced cell motility and deficient actin reinforcement . This indicates that phosphorylation is critical for HSPB1's mechanotransduction functions.
The signaling pathway connecting mechanical stimulation to HSPB1 phosphorylation involves activation of the p38 MAPK pathway, leading to MAPKAPK-2 activation, which directly phosphorylates HSPB1 at S15 and other sites. This mechanically activated phosphorylation pathway represents a crucial link between physical forces and cellular biochemical responses.
What are the functional consequences of HSPB1 phosphorylation at Serine 15 for cytoskeletal regulation?
HSPB1 phosphorylation at Serine 15 significantly impacts cytoskeletal dynamics and cellular mechanics through several mechanisms:
Non-phosphorylated HSPB1 binds to actin monomers and caps filament ends, inhibiting polymerization
Phosphorylation at S15 reduces binding affinity for actin, promoting filament elongation
This phosphorylation-dependent regulation allows for dynamic control of actin remodeling during mechanical stress
Phosphorylation of HSPB1 is required for normal actin reinforcement following mechanical stimulation
Only phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers
The recruitment of HSPB1 to high-tension structures in geometrically constrained cells requires phosphorylatable HSPB1
Research demonstrates that expression of wild-type HSPB1, but not non-phosphorylatable HSPB1, rescued certain characteristics of HSPB1-null cells including enhanced cell motility and deficient actin reinforcement following stretch stimulation . These findings highlight the critical role of HSPB1 phosphorylation in mechanosensitive cellular processes.
In the HSPB1-null cell model, cells exhibit enhanced motility and deficient actin reinforcement in response to mechanical stimulation. Re-expression of wild-type HSPB1 normalizes these behaviors, while non-phosphorylatable HSPB1 mutants fail to restore normal function . This demonstrates that phosphorylation is essential for HSPB1's ability to properly regulate cytoskeletal dynamics under mechanical stress.
How can researchers integrate phospho-HSPB1 analysis with functional cellular mechanics studies?
Integrating phospho-HSPB1 analysis with functional cellular mechanics requires multidisciplinary approaches:
Traction Force Microscopy (TFM) with simultaneous phospho-HSPB1 imaging:
Culture cells on polyacrylamide gels embedded with fluorescent beads
Apply mechanical stimulation (stretch or compression)
Fix cells at different timepoints
Stain for phospho-HSPB1 using Ab-15 antibody
Calculate traction forces from bead displacements
Correlate force generation with phospho-HSPB1 levels and distribution
Live-cell mechanics with phospho-reporters:
Transfect cells with FRET-based phospho-sensors
Apply mechanical stimulation using AFM or magnetic tweezers
Monitor real-time changes in phosphorylation and mechanical properties
Genetic Manipulation Approaches:
Utilizing CRISPR-Cas9 engineered HSPB1-null cells, researchers can perform rescue experiments with various HSPB1 constructs (wild-type, phospho-dead, phospho-mimetic) and measure resulting mechanical phenotypes .
Research has established that phosphorylation of HSPB1 is critical for normal cell behaviors including actin remodeling following stretch stimulation, cell spreading, and cell motility . Only phosphorylatable HSPB1, which displayed mechanoaccumulation to tensed actin stress fibers, restored these activities in HSPB1-null cells.
The relationship between HSPB1 phosphorylation and mechanical properties is bidirectional - mechanical stimulation induces HSPB1 phosphorylation, which in turn alters cell mechanical properties by regulating cytoskeletal organization. This feedback loop is essential for adaptive cellular responses to mechanical environments.
What advanced techniques can assess the dynamics of HSPB1 phosphorylation in response to mechanical stimuli?
Understanding the temporal dynamics of HSPB1 phosphorylation requires specialized techniques:
Time-course analysis with quantitative Western blotting:
Apply mechanical stimulus (stretch, shear, etc.)
Harvest cells at precise timepoints (30 seconds, 1, 2, 5, 10, 30, 60 minutes)
Perform Western blot with phospho-HSPB1 (Ab-15) antibody
Normalize to total HSPB1 levels
Plot phosphorylation kinetics
Live-cell phosphorylation sensors:
Genetically encoded FRET-based sensors for HSPB1 phosphorylation
Allows real-time monitoring in living cells
Can be combined with mechanical stimulation devices
Spatial-Temporal Integration:
Research has demonstrated that phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers in response to mechanical stimulation . This dynamic recruitment can be visualized in real-time using fluorescently tagged HSPB1 constructs and correlation with phospho-specific antibody staining at fixed timepoints.
In studies of mechanically stimulated cells, HSPB1 phosphorylation typically shows rapid induction (within minutes), followed by a more sustained phase lasting up to several hours. This biphasic response suggests different regulatory mechanisms and functional consequences in the immediate versus sustained response to mechanical stimulation.
The dynamics of HSPB1 phosphorylation are spatially regulated within the cell, with preferential phosphorylation occurring at sites of high mechanical stress, such as focal adhesions, stress fiber attachment points, and cell edges experiencing tension . This spatial regulation allows for localized control of cytoskeletal dynamics in response to heterogeneous mechanical environments.